Considering the expression of DRAM2 did not correlate with histology (Table 2), we chose to upregulate and silence DRAM2 expression in A549 (adenocarcinoma) and SK-MEM-1 (squamous carcinoma, hereinafter referred to as SK) for subsequent experiments. Here, DRAM2 is linked to squamous cell carcinoma.